Interwoven control of histone lactylation: metabolic enzymes LDHA/ACSS2 couple with epigenetic writer KAT2A
Visualized Cancer Medicine · 2026 · 7 · E1
DOI: 10.1051/vcm/2025016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visualized Cancer Medicine, online erschienen am 13.03.2026. Verfasst von Rongxuan Zhu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Histone lactylation is critically involved in the regulation of gene expression and the modulation of diverse cellular processes in both normal and tumor cells. A recent study by Zhu et al. [Cell Metab. 37 , 361–376] demonstrated that ACSS2 functions as a bona fide lactyl-CoA synthetase, converting lactate into lactyl-CoA. In response to elevated aerobic glycolysis and EGFR activation, ERK-mediated phosphorylation drives the nuclear translocation of ACSS2, promoting the formation of the ACSS2–KAT2A complex. KAT2A utilizes ACSS2-derived lactyl-CoA and acts as a lactyltransferase to promote histone lactylation, gene expression, tumor growth, and immune evasion.
Zitieren
APA
Zhu, R., Li, Y., Zhao, H., Meng, Y., Guo, D., Han, H., & Lu, Z. (2026). Interwoven control of histone lactylation: metabolic enzymes LDHA/ACSS2 couple with epigenetic writer KAT2A. Visualized Cancer Medicine, 7, E1. https://doi.org/10.1051/vcm/2025016
Vancouver
Zhu R, Li Y, Zhao H, Meng Y, Guo D, Han H, et al. Interwoven control of histone lactylation: metabolic enzymes LDHA/ACSS2 couple with epigenetic writer KAT2A. Visualized Cancer Medicine. 2026;7:E1. doi:10.1051/vcm/2025016
BibTeX
@article{Zhu2026,
author = {Zhu, Rongxuan and Li, Yuan and Zhao, Hong and Meng, Ying and Guo, Dong and Han, Hongkuan and Lu, Zhimin},
title = {Interwoven control of histone lactylation: metabolic enzymes LDHA/ACSS2 couple with epigenetic writer KAT2A},
journal = {Visualized Cancer Medicine},
year = {2026},
volume = {7},
pages = {E1},
doi = {10.1051/vcm/2025016}
}
EUVIMED